Heidi Ko/LinkedIn
Jun 1, 2025, 10:18
Heidi Ko: ASCO Is Not Just a Conference – It’s a Powerful Reminder of Progress in Cancer Research
Heidi Ko, Medical Director of Medical Affairs at Labcorp Drug Development, shared a post on LinkedIn:
“As I make my way to ASCO25, I’ve been reflecting on what this event truly represents in oncology!
ASCO is not just a conference, it is a powerful reminder of the strides we’ve made in cancer research and care, and the incredible potential that still lies ahead
Being in this field is both humbling and inspiring! We’ve achieved meaningful progress, and this year will be especially impactful, particularly for breast cancer
The updates, the science, the collaboration—ASCO always leaves me feeling inspired and genuinely hopeful for the future of cancer care
Sharing a few old pictures here and reminiscing on memories made along the way. Here’s to another incredible year ahead!!!
See you in Chicago!!”
More posts featuring ASCO25
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 26, 2025, 14:50
Jun 26, 2025, 14:20
Jun 26, 2025, 13:31